Dangerous Prescription Drugs

FDA Wants Opana ER Off Market

June 13, 2017
Invokana Gets FDA Black Box Warning for Amputation

May 19, 2017
Heartburn Drugs Linked to Heart Failure, ‘Silent’ Kidney Damage

March 1, 2017
Canada Expands Fluoroquinolone Antibiotic Warning

January 27, 2017
Asthma Risk in Children Linked to PPI Heartburn Drugs

January 19, 2017
PPI Heartburn Drugs May Raise Gut Infection Risk, Study Says

January 10, 2017

Drugwatch Archives

Looking for an older news story? Search the Drugwatch archives for any of our published news posts by month and category.

Month

Category

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.

If you would like to speak with a Drugwatch representative, please call 888-645-1617